▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁desc 12.3515625
rie 9.03125
bs 5.44140625
▁the 1.0146484375
▁apparent 9.171875
▁link 6.10546875
▁between 0.5419921875
▁pain 6.3515625
▁and 0.62744140625
▁dem 8.34375
oral 3.70703125
ization 0.4111328125
. 1.4609375
▁Chron 7.22265625
ic 0.042510986328125
▁pain 0.288818359375
▁is 1.39453125
▁always 6.1328125
▁accompanied 1.9765625
▁by 0.126708984375
▁negative 4.91015625
▁emot 1.5546875
ional 1.4228515625
▁experiences 2.810546875
▁and 2.091796875
▁blocks 11.046875
▁a 4.16796875
▁person 1.25
’ 24.53125
s 1.587890625
▁ability 1.5185546875
▁to 0.0513916015625
▁receive 6.18359375
▁joy 4.7421875
▁and 1.435546875
▁satisfaction 2.9375
▁from 1.2177734375
▁life 1.0712890625
. 0.348388671875
▁The 1.9267578125
▁research 3.69921875
▁investig 5.93359375
ates 0.481201171875
▁the 0.55810546875
▁development 6.140625
▁of 0.1849365234375
▁de 3.494140625
pression 0.288330078125
▁and 1.3115234375
▁anx 2.271484375
iety 0.01517486572265625
▁among 2.3515625
▁patients 2.5078125
▁receiving 4.2578125
▁ph 6.734375
arma 2.05859375
ce 0.0151214599609375
ut 0.00847625732421875
ical 0.0174407958984375
▁op 4.5546875
io 0.283935546875
ids 0.67138671875
▁and 2.380859375
▁medical 6.171875
▁am 6.87109375
ri 10.40625
ju 9.46875
ana 4.56640625
▁( 4.08203125
MM 5.2265625
) 4.46875
▁as 2.908203125
▁severe 9.3203125
▁pain 1.515625
kill 3.408203125
ers 0.0100860595703125
. 0.448486328125
▁It 3.244140625
▁comp 5.44921875
ares 0.045257568359375
▁the 0.6650390625
▁effic 6.7109375
acy 0.04248046875
▁of 0.27880859375
▁pres 5.38671875
cri 1.5498046875
ptions 1.1875
▁and 2.62109375
▁exam 6.19140625
ines 0.0216827392578125
▁the 0.43212890625
▁possibility 4.09375
▁of 0.10955810546875
▁post 6.62109375
- 0.9580078125
tre 2.41015625
at 0.0243377685546875
ment 0.0287933349609375
▁der 8.828125
p 7.703125
ession 4.9375
. 1.267578125
<0x0A> 2.037109375
There 5.015625
▁is 1.103515625
▁currently 4.7890625
▁a 1.12109375
▁severe 4.80078125
▁lack 3.29296875
▁of 0.033294677734375
▁information 2.076171875
▁about 1.3828125
▁the 0.47998046875
▁effects 3.048828125
▁of 0.08941650390625
▁op 1.267578125
i 3.56640625
ates 0.26318359375
. 3.763671875
▁They 4.890625
▁manage 8.890625
▁pain 3.51953125
▁successfully 5.890625
, 1.091796875
▁but 0.330078125
▁the 2.599609375
▁past 9.53125
▁few 2.5859375
▁dec 0.7060546875
ades 0.0008401870727539062
▁indicated 9.5
▁the 2.078125
▁growing 4.73046875
▁concern 3.6875
▁regarding 2.962890625
▁op 3.7421875
iate 0.7236328125
▁ab 1.4482421875
use 0.01251220703125
▁in 3.400390625
▁forms 10.46875
▁of 0.38525390625
▁over 3.23046875
d 0.4033203125
ose 0.218017578125
▁and 0.69140625
▁add 1.1142578125
iction 0.037384033203125
. 0.214111328125
▁A 4.01171875
▁more 5.6796875
▁manage 9.2734375
able 0.0148773193359375
▁and 2.16796875
▁sa 2.673828125
fer 0.0013685226440429688
▁alternative 1.6611328125
▁might 6.359375
▁be 0.2320556640625
▁medical 3.41015625
▁mar 0.6435546875
iju 0.03216552734375
ana 0.00798797607421875
. 1.2333984375
▁However 3.1484375
, 0.01251983642578125
▁the 1.6005859375
▁legal 3.85546875
▁status 1.232421875
▁and 2.94921875
▁novel 9.296875
ty 0.72314453125
▁of 0.2012939453125
▁this 1.7646484375
▁drug 2.142578125
▁do 5.30078125
▁not 0.08782958984375
▁allow 1.125
▁finding 8.8515625
▁a 2.396484375
▁large 4.40234375
▁number 1.4677734375
▁of 0.005123138427734375
▁studies 1.302734375
▁on 1.515625
▁its 1.0126953125
▁effect 2.15234375
iveness 0.448486328125
. 1.0322265625
▁Specifically 8.328125
, 0.146240234375
▁it 2.775390625
▁concerns 4.91796875
▁the 0.64794921875
▁emot 7.6796875
ional 0.017730712890625
▁condition 5.2734375
▁of 0.4248046875
▁patients 0.755859375
▁experien 6.08984375
cing 0.00152587890625
▁chron 1.037109375
ic 0.005283355712890625
▁pain 0.1083984375
. 0.6337890625
▁This 3.126953125
▁research 2.98046875
▁paper 5.7421875
▁a 2.234375
ims 0.001071929931640625
▁to 0.10198974609375
▁analyze 3.06640625
▁levels 9.7421875
▁of 0.0369873046875
▁de 0.64794921875
pression 0.0367431640625
▁and 0.28564453125
▁anx 0.04522705078125
iety 0.003993988037109375
▁among 0.72216796875
▁people 3.396484375
▁receiving 0.916015625
▁ther 7.75
apy 0.369140625
▁by 5.06640625
▁comparing 8.390625
▁the 0.94189453125
▁effects 2.056640625
▁of 0.033233642578125
▁ph 2.591796875
arma 0.0738525390625
ce 0.0027675628662109375
ut 0.0013141632080078125
ical 0.00499725341796875
▁op 0.263671875
io 0.186767578125
ids 0.057037353515625
▁and 0.36767578125
▁MM 2.998046875
. 1.23046875
<0x0A> 1.1318359375
The 1.35546875
▁study 2.0546875
▁was 2.177734375
▁conducted 0.7841796875
▁in 1.525390625
▁the 1.4619140625
▁form 2.482421875
▁of 0.01012420654296875
▁collection 9.8828125
▁and 1.6875
▁analysis 0.68798828125
▁of 0.0447998046875
▁statistical 4.1953125
▁data 0.1278076171875
. 0.89697265625
▁Part 5.02734375
icip 0.08660888671875
ants 0.057525634765625
▁were 0.71728515625
▁rec 3.26953125
ru 0.0040283203125
ited 0.00102996826171875
▁for 4.0546875
▁six 7.59765625
▁months 0.52197265625
▁at 3.787109375
▁two 2.513671875
▁major 5.37890625
▁pain 3.45703125
▁relief 5.32421875
▁cent 1.486328125
ers 0.1170654296875
▁in 0.6962890625
▁Israel 4.21875
. 0.416748046875
▁The 1.1845703125
▁research 2.16796875
ers 1.3857421875
▁used 2.712890625
▁The 8.0390625
▁De 4.33984375
pression 0.018341064453125
▁Module 9.8203125
▁of 0.93505859375
▁the 0.33935546875
▁Pat 2.375
ient 0.00913238525390625
▁Health 0.08843994140625
▁Question 0.017364501953125
naire 0.0264434814453125
▁and 3.30078125
▁the 0.74365234375
▁General 1.7373046875
ized 0.80810546875
▁An 0.0182342529296875
x 0.0005674362182617188
iety 0.004444122314453125
▁Dis 0.5703125
order 0.03997802734375
▁Sc 1.212890625
ale 0.07830810546875
▁to 1.8046875
▁interview 7.0625
▁participants 1.9853515625
, 3.6640625
▁evaluate 5.5859375
▁their 0.716796875
▁answers 6.515625
, 0.9111328125
▁and 0.1490478515625
▁conduct 4.4921875
▁the 2.294921875
▁study 2.2890625
. 0.2333984375
▁To 5.09375
▁specifically 9.9375
▁evaluate 2.5859375
▁and 4.3203125
▁compare 0.98291015625
▁the 0.322265625
▁prob 11.328125
abilities 0.271484375
▁of 0.138671875
▁de 0.88525390625
pression 0.038726806640625
▁or 4.5703125
▁anx 0.042633056640625
iety 0.001743316650390625
▁among 1.7275390625
▁the 2.234375
▁diverse 8.8984375
▁groups 1.546875
, 1.4599609375
▁the 1.001953125
▁study 2.697265625
▁used 1.6650390625
▁multiple 4.734375
▁log 2.91015625
istic 0.043548583984375
▁regression 0.103759765625
▁analysis 0.6904296875
▁and 2.53125
▁chose 8.796875
▁medical 7.6328125
▁mar 1.310546875
iju 0.01406097412109375
ana 0.0035552978515625
▁as 0.77294921875
▁the 1.0244140625
▁contro 11.1875
▁l 7.5859375
group 3.37109375
. 0.396240234375
<0x0A> 0.94287109375
This 3.3671875
▁type 6.05859375
▁of 0.01007843017578125
▁study 1.6640625
▁is 1.25
▁the 3.376953125
▁most 1.84765625
▁reve 9.0546875
aling 0.005985260009765625
▁and 1.0400390625
▁inclus 6.484375
ive 0.005260467529296875
, 2.333984375
▁as 1.916015625
▁it 0.339599609375
▁contains 4.984375
▁direct 6.59765625
▁responses 4.92578125
▁from 0.82763671875
▁a 3.86328125
▁large 0.9443359375
▁number 0.44873046875
▁of 0.0043182373046875
▁participants 1.369140625
. 0.625
▁All 4.65625
▁tools 9.328125
▁in 4.47265625
▁the 0.68896484375
▁form 3.533203125
▁of 0.041839599609375
▁question 1.73828125
na 0.035797119140625
ires 0.0012693405151367188
▁and 2.05078125
▁scales 3.20703125
▁have 3.669921875
▁already 4.6015625
▁been 0.1763916015625
▁used 1.9482421875
▁and 2.12109375
▁proved 4.25
▁their 1.8046875
▁effic 3.68359375
acy 0.0008959770202636719
▁for 3.68359375
▁collect 4.51953125
ing 0.017608642578125
▁analyt 8.265625
ical 0.26416015625
▁data 0.269775390625
. 0.419189453125
▁It 3.513671875
▁helps 4.81640625
▁to 0.98779296875
▁system 7.29296875
at 1.1484375
ize 0.0210418701171875
▁and 1.56640625
▁class 4.11328125
ify 0.005401611328125
▁distinct 9.2734375
▁kinds 6.13671875
▁of 0.02362060546875
▁information 3.2578125
▁for 3.9296875
▁subsequent 4.1484375
▁un 7.95703125
comp 5.45703125
licated 0.09747314453125
▁services 11.765625
. 0.6484375
▁Thus 4.39453125
, 0.0321044921875
▁research 4.55078125
ers 0.477294921875
▁can 1.3369140625
▁compare 3.947265625
▁the 0.9775390625
▁effects 2.95703125
▁of 0.10595703125
▁medic 4.41796875
ations 0.94775390625
▁on 1.82421875
▁patients 2.146484375
▁of 4.4765625
▁diverse 3.9375
▁age 2.697265625
▁groups 0.69482421875
, 0.91650390625
▁background 5.0
s 0.2152099609375
, 0.076904296875
▁physical 5.4296875
▁conditions 1.3837890625
, 0.094482421875
▁emot 5.44140625
ional 0.06793212890625
▁states 1.3349609375
, 0.1102294921875
▁and 0.445556640625
▁so 3.146484375
▁on 0.30126953125
. 0.09393310546875
<0x0A> 0.70947265625
The 1.1123046875
▁analysis 4.55859375
▁of 0.56787109375
▁any 8.6953125
▁human 6.046875
▁reaction 4.90234375
▁has 4.52734375
▁a 1.76171875
▁high 4.47265625
▁potential 3.412109375
▁of 1.6181640625
▁subject 6.05078125
iveness 3.82421875
▁and 1.3447265625
▁bias 2.212890625
, 1.9228515625
▁especially 2.416015625
▁regarding 4.40234375
▁people 4.4296875
▁in 3.962890625
▁severe 4.578125
▁pain 0.30712890625
▁and 2.66015625
▁un 5.37109375
stable 1.7587890625
▁emot 0.87890625
ional 0.17529296875
▁condition 2.490234375
. 0.0732421875
▁Perhaps 8.8828125
▁some 4.9140625
▁patients 2.375
▁tend 5.54296875
▁to 0.023956298828125
▁ex 2.560546875
agger 0.00328826904296875
ate 0.007732391357421875
▁their 0.73681640625
▁de 5.23046875
press 1.6044921875
ive 0.316162109375
▁state 3.158203125
▁or 1.7939453125
▁vice 7.3359375
▁vers 0.018768310546875
a 0.0006804466247558594
, 1.05078125
▁de 7.453125
- 4.703125
emph 0.94921875
as 0.0093536376953125
ize 0.163818359375
▁serious 6.765625
▁difficulties 5.87890625
. 0.8681640625
▁Because 6.16796875
▁the 2.263671875
▁survey 6.125
▁responses 6.5390625
▁were 1.5712890625
▁thoroughly 7.87109375
▁anonymous 5.33984375
, 0.4658203125
▁the 1.443359375
▁research 1.4814453125
ers 0.265380859375
▁were 1.474609375
▁unable 2.4609375
▁to 0.004421234130859375
▁carefully 8.703125
▁analyze 1.5625
▁each 3.94921875
▁patient 2.58984375
’ 26.859375
s 0.80908203125
▁reaction 3.66796875
▁and 2.361328125
▁compare 3.494140625
▁it 0.87158203125
▁to 1.2626953125
▁the 0.8056640625
▁actual 5.4140625
▁states 7.1640625
▁of 0.71337890625
▁condition 7.2734375
. 0.372314453125
▁More 6.83203125
▁accurate 3.8515625
▁answers 4.75
▁could 2.4765625
▁be 0.90380859375
▁obtained 0.994140625
▁by 1.349609375
▁professional 7.48046875
▁psych 2.234375
olog 0.32958984375
ists 0.004596710205078125
▁via 8.1171875
▁personal 3.943359375
▁communication 4.796875
▁and 1.8330078125
▁behavior 7.16796875
al 0.330810546875
▁an 9.9609375
l 1.9921875
ays 0.0638427734375
is 0.246337890625
. 0.258544921875
▁However 2.751953125
, 0.0037593841552734375
▁this 1.921875
▁method 2.857421875
▁of 2.32421875
▁research 2.2109375
▁is 0.93359375
▁way 7.7109375
▁more 1.5771484375
▁resource 6.71484375
- 0.52099609375
int 0.5927734375
ensive 0.0113525390625
▁and 0.60302734375
▁energy 8.671875
- 0.1591796875
consum 0.3330078125
ing 0.00606536865234375
. 0.58203125
<0x0A> 0.640625
Part 5.5390625
icip 0.11749267578125
ants 0.134765625
▁were 1.0166015625
▁rec 1.685546875
ru 0.003208160400390625
ited 0.0006093978881835938
▁for 1.1875
▁six 1.3466796875
▁months 0.025665283203125
▁at 0.472900390625
▁two 0.10919189453125
▁major 0.368896484375
▁pain 0.037109375
▁relief 0.03045654296875
▁cent 0.02630615234375
ers 0.0176239013671875
▁in 0.065185546875
▁Israel 0.032745361328125
. 0.1473388671875
▁All 3.51953125
▁patients 1.6279296875
▁experienced 5.48828125
▁chron 1.79296875
ic 0.0034122467041015625
▁pain 0.085205078125
▁for 3.482421875
▁at 0.77197265625
▁least 0.0022640228271484375
▁ 1.072265625
3 1.4384765625
▁months 0.228759765625
. 1.0185546875
▁The 1.4345703125
▁study 1.9423828125
▁included 2.328125
▁ 1.1240234375
8 2.921875
9 2.78515625
0 3.349609375
▁participants 1.4580078125
, 1.2734375
▁of 1.7705078125
▁which 0.39892578125
▁ 0.1466064453125
4 1.6669921875
7 2.474609375
4 2.771484375
▁( 2.1328125
5 0.1015625
9 11.1875
%) 1.0146484375
▁were 0.428466796875
▁treated 4.98046875
▁sole 6.90625
ly 0.00045990943908691406
▁with 0.52734375
▁op 0.939453125
io 0.313232421875
ids 0.1876220703125
, 1.30078125
▁ 0.72119140625
3 1.0947265625
2 2.138671875
9 2.572265625
▁( 0.046112060546875
4 1.2236328125
1 1.263671875
%) 0.1268310546875
▁were 1.2822265625
▁treated 0.646484375
▁with 0.17529296875
▁MM 0.74755859375
, 0.42236328125
▁and 0.1510009765625
▁ 0.1458740234375
7 3.083984375
7 2.408203125
▁( 0.1708984375
8 3.875
. 1.2060546875
6 3.00390625
%) 0.057220458984375
▁acquired 9.640625
▁both 1.0810546875
▁( 6.9609375
Fe 10.0703125
ing 2.76953125
old 0.022369384765625
▁et 1.423828125
▁al 0.027923583984375
., 0.314697265625
▁ 0.01302337646484375
2 0.152099609375
0 0.0006318092346191406
1 0.409912109375
7 2.076171875
). 0.1326904296875
▁The 1.322265625
▁remaining 7.2734375
▁ten 8.109375
▁participants 1.2978515625
▁who 5.56640625
▁did 1.4482421875
▁not 0.0079193115234375
▁receive 1.8515625
▁ph 3.095703125
arma 0.06646728515625
ce 0.0027751922607421875
ut 0.0010023117065429688
ical 0.0042724609375
▁op 1.017578125
io 0.09014892578125
ids 0.0218658447265625
▁and 1.7021484375
▁medical 2.134765625
▁mar 0.9033203125
iju 0.0206298828125
ana 0.002002716064453125
▁were 1.1416015625
▁with 5.77734375
dra 0.150634765625
wn 0.0010528564453125
▁from 0.27099609375
▁the 0.106689453125
▁analysis 4.6796875
▁in 4.83203125
▁the 1.16796875
▁research 4.41796875
. 0.78076171875
▁Therefore 4.85546875
, 0.008819580078125
▁it 3.796875
▁is 0.8076171875
▁not 2.646484375
▁possible 0.70166015625
▁to 0.0209197998046875
▁compreh 6.55078125
ens 0.05731201171875
ively 0.0222625732421875
▁compare 1.8447265625
▁patients 4.7890625
▁taking 4.29296875
▁medic 3.841796875
ations 0.44677734375
▁with 0.96630859375
▁those 1.16796875
▁who 1.2080078125
▁do 1.857421875
▁not 0.00988006591796875
. 0.76611328125
<0x0A> 0.64306640625
The 1.130859375
▁study 1.6796875
▁conducted 4.65234375
▁a 2.115234375
▁correlation 6.08203125
▁type 7.4765625
▁of 0.425048828125
▁research 1.970703125
▁with 2.9296875
▁variable 7.9296875
▁meas 6.38671875
ur 2.5
se 8.109375
. 1.5849609375
▁It 2.150390625
▁evaluated 4.734375
▁the 0.54833984375
▁inter 6.33984375
dep 3.69921875
end 0.015289306640625
ence 0.024444580078125
▁of 0.5595703125
▁various 4.0703125
▁factors 1.646484375
▁that 2.796875
▁affected 4.14453125
▁the 0.5693359375
▁physical 6.953125
▁and 0.90576171875
▁emot 0.4833984375
ional 0.0008258819580078125
▁condition 0.96630859375
▁of 0.10296630859375
▁patients 0.6083984375
▁experien 3.95703125
cing 0.0007233619689941406
▁chron 0.529296875
ic 0.0010633468627929688
▁pain 0.026885986328125
. 0.220947265625
▁For 3.802734375
▁example 1.072265625
, 0.0175018310546875
▁the 1.1787109375
▁survey 5.26171875
▁showed 3.28125
▁that 0.424072265625
▁the 1.716796875
▁ratio 6.98046875
▁of 0.132080078125
▁female 4.51171875
▁patients 0.76513671875
▁was 1.8603515625
▁remark 9.4140625
ably 0.0032291412353515625
▁higher 0.5146484375
▁in 2.744140625
▁the 0.990234375
▁op 4.45703125
i 3.607421875
ates 0.373046875
▁group 0.266845703125
▁compared 2.8203125
▁to 0.11029052734375
▁the 0.55712890625
▁MM 0.346435546875
▁group 0.26123046875
. 0.470947265625
▁In 3.025390625
▁turn 4.109375
, 0.0045166015625
▁people 6.0234375
▁on 5.33984375
▁op 1.5673828125
i 0.533203125
ates 0.00968170166015625
▁were 1.0859375
▁more 0.98828125
▁likely 0.357666015625
▁to 0.05908203125
▁report 3.07421875
▁major 5.859375
▁de 0.40625
press 1.263671875
ive 0.0081634521484375
▁dis 0.4716796875
orders 1.4560546875
. 1.8203125
<0x0A> 2.55078125
The 1.111328125
▁question 5.734375
na 1.1474609375
ires 0.001697540283203125
▁used 2.048828125
▁different 8.2890625
▁variable 8.65625
▁measures 2.640625
▁to 1.6220703125
▁collect 2.349609375
▁information 1.998046875
. 1.48828125
▁For 1.9384765625
▁example 0.22021484375
, 0.00799560546875
▁it 4.140625
▁included 2.5
▁compreh 8.6171875
ensive 0.03216552734375
▁so 6.5703125
cio 0.09912109375
- 0.5927734375
dem 0.09619140625
ographic 0.05572509765625
▁data 1.0693359375
: 4.8984375
▁gen 9.3203125
de 6.44921875
, 0.9189453125
r 12.03125
▁age 1.7734375
, 0.11370849609375
▁country 5.24609375
, 1.2431640625
▁type 5.12109375
▁of 0.06201171875
▁residence 2.892578125
▁( 3.2421875
urban 1.9755859375
/ 2.845703125
r 0.0762939453125
ural 0.058349609375
), 0.254150390625
▁years 5.51953125
▁of 0.173095703125
▁education 0.703125
, 0.1983642578125
▁and 1.8720703125
▁employ 3.7265625
ment 0.0122833251953125
▁status 0.452392578125
. 0.18994140625
▁Pat 4.0625
ients 0.09844970703125
▁were 1.1904296875
▁also 0.83251953125
▁asked 0.60302734375
▁about 1.19140625
▁their 0.60205078125
▁medical 2.78125
▁history 0.53955078125
▁over 8.65625
▁the 0.171875
▁years 3.87890625
▁and 1.78515625
▁the 1.859375
▁current 3.42578125
▁presence 5.953125
▁of 0.059661865234375
▁any 2.6171875
▁severe 4.6875
▁dise 1.6220703125
ases 0.0020599365234375
▁such 4.06640625
▁as 0.0081329345703125
▁heart 2.38671875
▁failure 2.19921875
, 0.187744140625
▁di 1.9609375
ab 0.005191802978515625
etes 0.00801849365234375
, 0.131103515625
▁ar 3.701171875
th 0.172119140625
rit 0.04827880859375
is 0.0229339599609375
, 0.049530029296875
▁and 1.607421875
▁so 0.796875
▁on 0.0411376953125
. 0.053009033203125
▁The 1.912109375
▁third 7.3203125
▁measure 3.6875
▁of 1.923828125
▁the 1.033203125
▁question 2.74609375
naire 0.282470703125
▁was 0.91796875
▁indicated 9.765625
▁by 0.634765625
▁information 6.5
▁on 1.5712890625
▁any 5.25390625
▁twelve 13.546875
- 1.1826171875
month 0.37060546875
▁and 5.80859375
▁lifetime 3.25390625
▁drug 4.66796875
▁and 3.609375
▁alco 0.08404541015625
hol 0.0012111663818359375
▁consumption 2.806640625
▁. 9.640625
In 5.01953125
▁addition 1.11328125
, 0.140625
▁the 1.0830078125
▁record 8.1875
▁included 2.015625
▁a 2.498046875
▁pain 6.18359375
▁measurement 4.01953125
▁scale 0.96142578125
▁from 3.8203125
▁ 0.466796875
0 0.417724609375
▁to 0.46484375
▁ 0.01169586181640625
1 0.09295654296875
0 0.07879638671875
▁to 4.5546875
▁evaluate 1.4482421875
▁dis 6.0234375
com 0.174560546875
fort 0.00682830810546875
▁feelings 6.8203125
▁during 3.255859375
▁the 0.86376953125
▁last 1.4765625
▁month 1.6142578125
. 0.393310546875
<0x0A> 1.306640625
Am 6.58984375
ong 0.10333251953125
▁all 2.31640625
▁participants 1.869140625
▁in 3.560546875
▁the 0.1727294921875
▁study 0.37158203125
, 0.07110595703125
▁ 0.6279296875
4 1.7578125
2 2.771484375
. 1.8916015625
2 2.296875
% 0.158935546875
▁suffered 4.8828125
▁from 0.1339111328125
▁de 1.70703125
pression 0.1728515625
, 1.07421875
▁and 1.748046875
▁ 0.1572265625
3 1.6953125
7 2.1953125
% 2.7890625
▁experienced 2.34375
▁excess 7.79296875
ive 0.098876953125
▁anx 0.24609375
iety 0.005290985107421875
. 0.3583984375
▁The 1.4228515625
▁pl 11.1953125
ur 1.11328125
ality 0.0010805130004882812
▁of 0.210693359375
▁de 3.533203125
press 1.453125
ive 0.03765869140625
▁dis 1.7119140625
orders 0.07867431640625
▁among 3.744140625
▁p 7.359375
ate 3.619140625
ints 0.25927734375
▁in 4.0859375
▁the 0.390869140625
▁op 1.33203125
i 1.0380859375
ates 0.0121612548828125
, 6.859375
▁medical 2.806640625
▁mar 0.09747314453125
iju 0.04205322265625
ana 0.001544952392578125
, 0.222900390625
▁and 0.06890869140625
▁mixed 6.2890625
▁OP 8.5078125
MM 6.8359375
▁groups 0.54833984375
▁number 8.0234375
ed 0.01416015625
▁ 0.1195068359375
5 2.158203125
7 2.484375
. 0.217041015625
1 2.359375
%, 0.270263671875
▁ 0.00991058349609375
2 3.013671875
2 2.4453125
. 0.0946044921875
3 2.23046875
%, 0.1317138671875
▁and 0.045654296875
▁ 0.005218505859375
5 3.1875
1 2.625
. 0.16748046875
4 2.1328125
%, 0.400146484375
▁respectively 0.020263671875
. 0.295654296875
▁The 1.470703125
▁pl 4.6328125
ur 0.032470703125
ality 0.0002428293228149414
▁of 0.046783447265625
▁anx 0.7998046875
iety 0.02923583984375
▁contained 11.1640625
▁ 0.5986328125
4 1.587890625
8 2.3828125
. 0.062744140625
4 2.3046875
% 0.533203125
▁among 1.4755859375
▁OP 6.125
▁patients 8.21875
, 0.33740234375
▁ 0.124267578125
2 1.5009765625
1 2.423828125
. 0.1280517578125
5 2.42578125
% 0.013885498046875
▁among 0.40966796875
▁MM 0.396728515625
▁patients 0.26953125
, 0.0158233642578125
▁and 0.0178375244140625
▁ 0.04205322265625
3 1.21875
8 2.619140625
. 0.146484375
7 2.279296875
% 0.016082763671875
▁among 0.2196044921875
▁OP 4.109375
MM 0.35205078125
▁participants 3.681640625
. 0.254150390625
▁Pat 5.90234375
ients 0.03094482421875
▁who 2.396484375
▁took 2.876953125
▁strong 8.1171875
▁op 1.1611328125
i 1.3818359375
ates 0.00957489013671875
▁were 1.7197265625
▁t 8.578125
ended 1.271484375
▁to 0.018035888671875
▁place 10.390625
▁their 3.720703125
▁pain 2.6875
▁on 3.466796875
▁a 0.8759765625
▁scale 2.341796875
▁of 0.607421875
▁ 0.345703125
9 2.78515625
▁to 1.3896484375
▁ 0.0180206298828125
1 0.0232391357421875
0 0.08087158203125
▁F 11.1640625
( 4.8046875
eing 15.609375
old 4.88671875
▁et 0.145263671875
▁al 0.018157958984375
., 0.031829833984375
▁ 0.0254974365234375
2 0.0015649795532226562
0 0.0002073049545288086
1 0.004154205322265625
7 0.0310516357421875
). 0.08673095703125
▁They 5.0703125
▁were 1.2783203125
▁also 1.2333984375
▁an 8.671875
gu 4.05859375
ished 0.0633544921875
▁em 8.296875
otion 0.0567626953125
ally 0.0132293701171875
▁and 1.12890625
▁react 6.9921875
ed 0.06048583984375
▁rad 9.4296875
ically 0.06903076171875
▁neg 5.296875
atively 0.00579071044921875
▁to 0.373779296875
▁almost 5.34375
▁all 1.1474609375
▁survey 8.0703125
▁questions 0.669921875
. 0.28759765625
▁Pat 4.234375
ients 0.01194000244140625
▁who 1.1259765625
▁took 1.357421875
▁only 5.453125
▁MM 0.77685546875
▁or 3.185546875
▁mixed 3.453125
▁medic 2.7890625
ations 0.364013671875
▁course 12.328125
▁had 2.431640625
▁a 1.23828125
▁significantly 2.58984375
▁more 4.0390625
▁stable 3.361328125
▁emot 1.27734375
ional 0.00978851318359375
▁state 0.794921875
▁and 1.3740234375
▁cop 5.67578125
ed 0.8193359375
▁with 0.74560546875
▁pain 1.537109375
▁more 1.62890625
▁manage 6.7734375
able 2.38671875
. 0.477294921875
<0x0A> 0.70849609375
One 5.26953125
▁of 0.5791015625
▁the 0.020843505859375
▁major 2.515625
▁limitations 2.810546875
▁is 3.828125
▁the 0.52099609375
▁ins 4.78515625
u 0.03240966796875
fficient 0.1505126953125
ly 4.74609375
▁high 3.0078125
▁response 3.083984375
▁rate 0.1361083984375
, 2.671875
▁ 4.5
5 1.966796875
7 2.009765625
% 2.0859375
▁instead 7.3671875
▁of 0.010650634765625
▁ 0.71875
7 1.5419921875
0 1.494140625
% 1.068359375
▁( 1.9052734375
Fe 0.54541015625
ing 0.014556884765625
old 0.0017604827880859375
▁et 0.020782470703125
▁al 0.005100250244140625
., 0.01425933837890625
▁ 0.007213592529296875
2 0.0007576942443847656
0 0.0004665851593017578
1 0.0018768310546875
7 0.0110015869140625
). 0.043914794921875
▁It 2.7734375
▁can 3.2265625
▁be 0.410400390625
▁fairly 8.3359375
▁explained 1.65234375
▁by 0.1925048828125
▁the 0.32470703125
▁weak 8.1796875
▁focus 7.08984375
▁of 0.45703125
▁respond 6.34375
ents 0.1507568359375
▁who 3.462890625
▁have 4.0546875
▁overcome 8.046875
▁severe 2.431640625
▁pain 0.454345703125
▁sens 8.8203125
ations 1.16015625
▁and 1.2216796875
▁de 4.4921875
press 1.744140625
ive 0.251953125
▁episodes 4.26171875
. 0.6142578125
▁It 3.33203125
▁is 0.80029296875
▁not 2.62890625
▁clear 4.234375
▁how 1.662109375
▁to 3.529296875
▁use 5.328125
▁these 2.998046875
▁statistics 3.474609375
, 2.517578125
▁as 1.3837890625
▁they 1.373046875
▁still 6.1875
▁may 4.81640625
▁be 1.345703125
▁relevant 5.421875
▁for 1.421875
▁the 1.83984375
▁overall 4.45703125
▁analysis 3.064453125
. 1.0693359375
